You are here: Industry Insights > TFDA

News List

KYOWA, Bora Pharmaceuticals Enter Mfg. Pact contractpharma
August 11, 2021
Upon approval in Japan, Bora will be the commercial manufacturing site for the generic product production.
KYOWA Pharmaceutical Industry Co. Ltd. Partners with Bora Pharmaceuticals to Manufacture Generic Product for Filing in Japan prnasia
August 05, 2021
KYOWA Pharmaceutical Industry Co. Ltd., a premier Japanese pharmaceutical company, has contracted with Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals for the manufacturing of generic product for filing in Japan.
WHO confirm Tanzania FDA as Africa's first well-functioning regulatory body pharmafile
December 12, 2018
Tanzania has become the first country in Africa to achieve a well-functioning regulatory system for medical products, according to the World Health Organization (WHO).
TWi Biotechnology gets TFDA nod to treat Inherited Epidermolysis Bullosa biospectrumasia
February 27, 2018
TFDA approves phase 2 clinical trial of AC-203 for the treatment of inherited Epidermolysis Bullosa (EB)